PBIGF

$0.10-$0.02 (-19.42%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$0.10 – $0.35

0% from low

Exchange

OTC Link

Change$-0.84

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2027	$3M	+0.0%	$-0.08	$-0.08–$-0.08	—	1
2028	$325M	+10818.5%	$0.18	$0.18–$0.18	0.5×	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Intrinsic value

$0.05

Price

$0.10

Implied downside

-55%

Symbol	Price	Today	Mkt cap	P/E
PBIGFParadigm Biopharmaceuticals Limited	$0.10	-19.42%	$60M	—
AURXNuo Therapeutics, Inc.	$0.83	+0.00%	$40M	—
IUGNFImugene Limited	$0.08	+0.00%	$37M	—
KNTPFKintor Pharmaceutical Limited	$0.24	+0.00%	$112M	—
MSCLFSatellos Bioscience Inc.	$6.25	+11.81%	$97M	—
ORXOFOrexo AB (publ)	$1.55	+0.00%	$54M

Source: Financial Modeling Prep · peers by sector/industry

No one on the platform currently holds PBIGF.

Institutions holding (13F)

No tracked institution reports a position in PBIGF as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Execution date	Ratio
2025-02-07	5-for-4

No one on the platform has traded PBIGF yet.